Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01812174 · ClinicalTrials.gov registry record · NA
On-X Heart Valve - 17mm Aortic and 23mm Mitral
A NA study, sponsored by On-X Life Technologies.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01812174: Clinical Trial NA study, sponsored by On-X Life Technologies.
NCT01812174 is a NA study that was terminated before completion, run by On-X Life Technologies. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01812174, a NA study, was terminated before completion, sponsored by On-X Life Technologies.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study examines the hemodynamic and hemolytic properties of two additional smaller size valves to the On-X line of valves already approved by FDA.
Primary Outcome
Number of subjects with a valve related adverse event at 1 year.
Interventions
- DEVICE 17mm aortic valve (On-X )
- DEVICE 23mm mitral valve (On-X)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-11-18 |
| Est. Completion | 2018-12-07 |
| Phase | NA |
Why NCT01812174 stopped before completion
NCT01812174 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which 17mm aortic valve (On-X ) is the first listed.
NCT01812174 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01812174 about?
NCT01812174 is a clinical study titled "On-X Heart Valve - 17mm Aortic and 23mm Mitral". This study examines the hemodynamic and hemolytic properties of two additional smaller size valves to the On-X line of valves already approved by FDA.
What is the current status of trial NCT01812174?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2011-11-18. Estimated completion is 2018-12-07.
What interventions are being tested in trial NCT01812174?
The interventions under investigation include: 17mm aortic valve (On-X ) (DEVICE), 23mm mitral valve (On-X) (DEVICE).
Who is sponsoring clinical trial NCT01812174?
This trial is sponsored by On-X Life Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01812174's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI